Recursion Pharmaceuticals, Inc. RXRX Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s goodwill?
- Recursion Pharmaceuticals, Inc. (RXRX) reported goodwill of $160.17M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s goodwill changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s goodwill increased by 1.3% year-over-year, from $158.11M to $160.17M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s goodwill?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s goodwill has grown at a 189.2% compound annual growth rate (CAGR), from $801K to $162.16M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.